Mach-1 Financial Group »

Apellis Pharmaceuticals shares owned by Mach-1 Financial Group

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Mach-1 Financial Group from 13F filings

Historical chart of Mach-1 Financial Group investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Mach-1 Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Mach-1 Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $228k 5.7k 40.23

More positions owned by Mach-1 Financial Group

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
First Tr Exchange-traded Growth Strength (FTGS)
Vanguard Bd Index Fds Intermed Term (BIV)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
First Tr Exchange-traded Core Investment (FTCB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
First Tr Exchng Traded Fd Vi Smith Unconstrai (UCON)
First Tr Exchange-traded SHS (FDL)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Wcm Intl Equity (WCMI)
Wal-Mart Stores (WMT)
First Tr Exchange-traded Intermediate Dur (FIIG)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Ishares Tr Rus 2000 Grw Etf (IWO)

View all positions for Mach-1 Financial Group

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals